Blessing Health Palmyra Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 6996 County Road 326, Palmyra, MO 63461 Phone: 573-769-3710 Fax: 573-769-3753 |
Palmyra Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6996 County Road 326, Palmyra, MO 63461 Phone: 573-769-3710 Fax: 573-769-3753 |
Hannibal Clinic @ Palmyra Family Medicine Medicare: Medicare Enrolled Practice Location: 1811 S Main St, Palmyra, MO 63461 Phone: 573-769-2231 Fax: 573-769-3953 |
News Archive
DATATRAK International, Inc., the leader in developing cloud-based, unified eClinical technologies and delivering related services for the clinical trials industry, today announced three CRO Enterprise Partners have expanded their agreements. These industry-leading organizations have chosen to boost their global licensing capacity and extended their relationship with DATATRAK.
Human Genome Sciences, Inc. announced today that several abstracts related to BENLYSTA (belimumab) and systemic lupus erythematosus will be presented at the annual meeting of the American College of Rheumatology/ Association of Rheumatology Health Professionals, being held in Chicago, IL from November 4 to November 9, 2011.
The first landmark randomized clinical trial for a cardiac drug regimen in Duchenne muscular dystrophy (DMD) is testing whether earlier treatment can stop or slow down heart damage that usually kills people with the disease.
Peptides that target blood vessels in fat and cause them to go into programmed cell death (termed apoptosis) could become a model for future weight-loss therapies, say University of Cincinnati (UC) researchers.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced the publication of data from a mouse model of diet-induced obesity in the June, 2010 edition of the journal Endocrinology. The data showed that mice treated with XOMA 052 both prophylactically and therapeutically experienced improvement in measures associated with diabetes and cardiovascular disease including reduction in glycosylated hemoglobin levels, improvement in glucose control, improved beta-cell survival and function, and a reduction in total cholesterol without reduction in high density lipoprotein.
› Verified 7 days ago